Tag: UCLA
-
Organoids Uncover Glioblastoma’s Treatment Evasion
New Frontiers in Brain Cancer Research Researchers at UCLA have advanced the study of glioblastoma, one of the most aggressive brain cancers, by developing sophisticated miniature 3D tumor organoids. These organoids mimic the architecture and cell interactions of human brain tissue more closely than traditional cell cultures, offering a powerful platform to observe how glioblastoma…
-
Organoids Reveal Glioblastoma’s True Path to Treatment Evasion
Organoids: A new lens into glioblastoma’s stubborn nature Glioblastoma, one of the most aggressive brain cancers, has long frustrated clinicians with its ability to bend to treatment pressures. A pioneering effort from researchers at UCLA has pushed the boundaries of how we study this deadly disease. By growing advanced miniature 3D tumor organoids that mimic…
-
Organoids Reveal Glioblastoma’s Evasion Tricks in Brain-Murking Mini-Tumors
New 3D organoid models bring glioblastoma closer to the living brain Glioblastoma, the most aggressive form of brain cancer, has long shown a stubborn resistance to treatments. Researchers at UCLA have developed advanced miniature 3D tumor organoid models that mirror many aspects of human brain tissue. These organoids recreate the complex interactions between glioblastoma cells…
-
Web World Models: AI Agents Explore Consistent, Persistent Environments
What are Web World Models? Scientists at Princeton University, UCLA, and the University of Pennsylvania are advancing a concept called web world models. The idea is simple in spirit but powerful in potential: give artificial intelligence agents a set of persistent, browser-like environments to explore, where the environment’s structure is defined by web code and…
-
Shorter Hormone Therapy May Suffice for Prostate Cancer
New findings suggest shorter hormone therapy could be enough for many men with prostate cancer For years, androgen deprivation therapy (ADT) has been a mainstay in treating prostate cancer, often prescribed for extended periods to slow tumor growth. But a new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center points to…
-
Rising Diverticulitis in Americans Under 50: What the Study Means
Summary: A Disturbing Trend A growing number of Americans under 50 are being diagnosed with diverticulitis, a painful gut condition once thought to affect mainly older adults. A collaborative study from leading institutions highlighted a marked uptick in hospitalizations for diverticulitis among younger adults, signaling a shift in who bears the burden of this digestive…
-
Why Diverticulitis Is Surging in Americans Under 50: What It Means for Young Adults
Overview: A Growing Concern for Young Adults Diverticulitis, once considered a condition mainly affecting older adults, is increasingly striking people under 50 in the United States. A recent study from researchers at UCLA and Vanderbilt University highlights a troubling trend: younger adults are developing a severe gut disorder at higher rates, leading to more hospitalizations…
-
ADA-SCID Gene Therapy Shows Long-Term Success in Children
Breakthrough in pediatric ADA-SCID treatment A large international study led by researchers from Great Ormond Street Hospital (GOSH), University College London (UCL), and the University of California, Los Angeles (UCLA) has demonstrated the long-term safety and effectiveness of a standard lentiviral gene therapy for ADA-SCID, a rare and life-threatening immune disorder. The cohort, followed for…
-
Experimental gene therapy restores immune system function in ADA-SCID children
Groundbreaking therapy offers durable immune restoration for ADA-SCID An experimental gene therapy developed by researchers at UCLA, University College London (UCL) and Great Ormond Street Hospital (GOSH) has achieved durable restoration of immune system function in 59 of 62 children born with ADA-SCID, a rare and often deadly genetic immune disorder. The long-term follow-up results,…
-
Experimental Gene Therapy Restores Immune Function in Children with ADA-SCID: A Breakthrough in Immunodeficiency Treatment
Overview: A new path for ADA-SCID treatment Researchers from UCLA, University College London, and Great Ormond Street Hospital have reported a remarkable milestone in the fight against ADA-SCID, a rare and often fatal genetic immune disorder. In a long-term study published in the New England Journal of Medicine, an experimental gene therapy restored and sustained…